AbbVie Inc.
Single-Chain Trail-Receptor Agonist Proteins

Last updated:

Abstract:

Provided herein are specific TRAIL receptor agonist proteins, nucleic acids encoding the same, and methods of treating a subject having a TRAIL-associated disease or disorder. The TRAIL receptor agonist proteins provided herein comprise three soluble TRAIL domains and an Fc fragment. The TRAIL receptor agonist proteins are substantially non-aggregating and suitable for therapeutic, diagnostic and/or research applications.

Status:
Application
Type:

Utility

Filling date:

14 Aug 2020

Issue date:

11 Feb 2021